A multicenter, randomized, open label study to compare the safety and efficacy of levofloxacin with that of imipenem/cilastatin in the treatment of nosocomial pneumonia.
Phase of Trial: Phase III
Latest Information Update: 26 May 2009
At a glance
- Drugs Imipenem/cilastatin; Levofloxacin
- Indications Bacterial infections; Nosocomial pneumonia
- Focus Therapeutic Use
- 26 May 2009 Planned number of patients changed from 400 to 438 as reported by ClinicalTrials.gov.
- 20 Nov 2005 New trial record.